Catalyst Pharmaceuticals CPRX
CPRX
$31.49 +0.00 (+0.00%)
At close: Jul 21, 2026 · 4:00 PM EDT

Catalyst Pharmaceuticals (CPRX) Consolidated Net Income (2010 - 2026)

Updated

Catalyst Pharmaceuticals (CPRX) reported Consolidated Net Income of $63.73 million for Q1 2026, up 12.3% from $56.74 million a year earlier and up 20.9% from the prior quarter.

Analysis

Catalyst Pharmaceuticals (CPRX) Consolidated Net Income (2010 - 2026) Analysis & Trends

Over the twelve months ended Mar 31, 2026, Catalyst Pharmaceuticals' Consolidated Net Income came in at $221.32 million, up 12.1% year-over-year; for FY2025, it came in at $214.33 million, up 30.8% from FY2024.

  • Consolidated Net Income has a five-year compound annual growth rate of 23.4% (FY2020 to FY2025).
  • By year, Consolidated Net Income came in at $163.89 million in FY2024 (+129.5%), $71.41 million in FY2023 (-14.0%), $83.08 million in FY2022 (+110.4%) and $39.48 million in FY2021 (-47.3%).
  • The Q1 2026 figure ranks as the highest quarterly Consolidated Net Income in data going back to Q3 2010.
  • Year over year, Consolidated Net Income gained in six of the last seven quarters, with growth averaging 38.1%.
  • The high point for year-over-year Consolidated Net Income in five years was Q4 2022 (growth of 173.6%); the low point was Q3 2021 (a decline of 76.2%).
  • Per Business Quant data, the three quarters before Q1 2026 came in at $52.7 million (Q4 2025), $52.78 million (Q3 2025) and $52.11 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 5.53 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.62 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 2.51 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -10.50 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -237.00 Mn
10 Catalyst Pharmaceuticals 3.85 Bn 1.04 Bn 134.92 Mn 63.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 63.73 Mn
Dec 31, 2025 52.70 Mn
Sep 30, 2025 52.78 Mn
Jun 30, 2025 52.11 Mn
Mar 31, 2025 56.74 Mn
Dec 31, 2024 55.94 Mn
Sep 30, 2024 43.88 Mn
Jun 30, 2024 40.79 Mn
Mar 31, 2024 23.28 Mn
Dec 31, 2023 34.84 Mn
Sep 30, 2023 -30.76 Mn
Jun 30, 2023 37.76 Mn
Mar 31, 2023 29.57 Mn
Dec 31, 2022 25.47 Mn
Sep 30, 2022 22.75 Mn
Jun 30, 2022 21.62 Mn
Mar 31, 2022 13.24 Mn
Dec 31, 2021 9.31 Mn
Sep 30, 2021 10.33 Mn
Jun 30, 2021 12.18 Mn
API Access

Catalyst Pharmaceuticals Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=CPRX&period=max&api_key=YOUR_API_KEY